Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study.

Hess, Lisa M; Chen, Yongmei; Abada, Paolo B; Konig, Heiko; Walgren, Richard A

Hess, Lisa M; Chen, Yongmei; Abada, Paolo B; Konig, Heiko; Walgren, Richard A.

Afiliação

Hess LM; Eli Lilly and Company, Indianapolis, IN, USA.
Chen Y; Eli Lilly and Company, Indianapolis, IN, USA.
Abada PB; Eli Lilly and Company, Indianapolis, IN, USA.
Konig H; Eli Lilly and Company, Indianapolis, IN, USA.
Walgren RA; Eli Lilly and Company, Indianapolis, IN, USA.

Adv Hematol ; 2022: 8262787, 2022.

Article em En | MEDLINE | ID: mdl-36620778

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812614
https://dx.doi.org/10.1155/2022/8262787

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812614
https://dx.doi.org/10.1155/2022/8262787

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article